Association of Severe Vitamin D Deficiency with Hospitalization in the Previous Year in Hospitalized Exacerbated COPD Patients
Boyu Li,Meishan Liu,Ying Wang,Hong Zhang,Lingling Xuan,Kewu Huang,Zhuoling An
DOI: https://doi.org/10.2147/copd.s461029
2024-06-26
International Journal of COPD
Abstract:Boyu Li, 1, &ast Meishan Liu, 2, &ast Ying Wang, 2 Hong Zhang, 2 Lingling Xuan, 1 Kewu Huang, 2 Zhuoling An 1 1 Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Kewu Huang; Zhuoling An, Beijing Chao-Yang Hospital, Capital Medical University, 8 Gongtinan Road, Beijing, People's Republic of China, Tel/Fax +86 010 85231167 ; Tel/Fax +86 010 85231362, Email ; Purpose: Vitamin D deficiency (VDD, 25-hydroxyvitamin D < 20 ng/mL) has been reported associated with exacerbation of chronic obstructive pulmonary disease (COPD) but sometimes controversial. Research on severe vitamin D deficiency (SVDD, 25-hydroxyvitamin D < 10 ng/mL) in exacerbation of COPD is limited. Patients and Methods: We performed a retrospective observational study in 134 hospitalized exacerbated COPD patients. 25-hydroxyvitamin D was modeled as a continuous or dichotomized (cutoff value: 10 or 20 ng/mL) variable to evaluate the association of SVDD with hospitalization in the previous year. Receiver operator characteristic (ROC) analysis was performed to find the optimal cut-off value of 25-hydroxyvitamin D. Results: In total 23% of the patients had SVDD. SVDD was more prevalent in women, and SVDD group tended to have lower blood eosinophils counts. 25-hydroxyvitamin D level was significantly lower in patients who were hospitalized in the previous year (13.6 vs 16.7 ng/mL, P = 0.044), and the prevalence of SVDD was higher (38.0% vs 14.3%, P = 0.002). SVDD was independently associated with hospitalization in the previous year [odds ratio (OR) 4.34, 95% CI 1.61– 11.72, P = 0.004] in hospitalized exacerbated COPD patients, whereas continuous 25-hydroxyvitamin D and VDD were not ( P = 0.1, P = 0.9, separately). The ROC curve yielded an area under the curve of 0.60 (95% CI 0.50– 0.71) with an optimal 25-hydroxyvitamin D cutoff of 10.4 ng/mL. Conclusion: SVDD probably showed a more stable association with hospitalization in the previous year in hospitalized exacerbated COPD patients. Reasons for lower eosinophil counts in SVDD group needed further exploration. Keywords: association, vitamin D, severe deficiency, hospitalization for exacerbation, COPD Chronic obstructive pulmonary disease (COPD) carries a heavy healthcare burden because of its increasing prevalence, 1 frequent exacerbations, and its requirement for hospital admission. 2 The current treatment options are insufficient because of the unclear underlying cellular and molecular mechanisms of COPD. 3,4 Vitamin D deficiency (25-hydroxyvitamin D level < 20 ng/mL, VDD) 5 is prevalent in COPD. 6,7 It has been implicated as a risk factor for airflow limitation and pulmonary structure and function. 8–10 Its association with lung function decline and exacerbations in COPD is extensively reported, but sometimes controversial. 11,12 The Global Initiative for Chronic Obstructive (GOLD, 2024) recommends that all patients hospitalized for exacerbation of COPD be assessed and investigated for severe vitamin D deficiency (25-hydroxyvitamin D level < 10 ng/mL, SVDD), 5 followed by supplementation if required, based mainly on inference of meta-analysis. 13 However, real-world research about SVDD in severe COPD exacerbation is limited. Therefore, we performed a retrospective observational study in patients hospitalized for exacerbation of COPD to evaluate the association of SVDD with hospitalization for exacerbation. Demographic and clinical data were retrospectively collected at Beijing Chao-Yang Hospital, Capital Medical University (Beijing, China) from January 2019 to October 2022. The inclusion criteria were age >40 years, a post-bronchodilator ratio of forced expiratory volume in 1 s to forced vital capacity (FEV 1 /FVC) <0.7 at first diagnosis for COPD according to the diagnostic criteria of GOLD, 13 exacerbation of COPD as a primary discharge diagnosis (including both acute exacerbation of COPD defined as episodes of symptom worsening that have significant adverse consequences for patients 14 and pneumonic COPD with radiographic consolidation 15 ), and available data on 25-hydroxyvitamin D. After excluding patients taking vitamin D supplements (n = 24), 134 patients were enrolled -Abstract Truncated-
respiratory system